CA 19-9 is a tumor marker that can only be requested by a physician and is not available to consumers.
ECLIA methodReference range
of diagnostic sensitivity of CA 19-9 elevations in malignant diseases:
Pancreatic carcinoma: 72-90%Galignant carcinoma
cancer: 18-58%Magic carcinoma
liver cell carcinoma: 22-49%
Biological half-life: 4-8 days.
Concurrent determination of CEA increases sensitivity.
CA 19-9 is also elevated in a wide range of benign diseases of the mentioned organ systems
You should confirm in the comments during the order that you take into account the possibility of an incriminating result. Please confirm this in the comments during the order "I am adequately informed and accept the possibility that mentally incriminating results may be found."
Tumor markers are substances, usually proteins, that your body makes in response to cancer or that are made by the cancer itself. We can measure tumor markers in your blood, urine, cerebrospinal fluid or tissue material.
Some tumor markers belong to one type of cancer; others occur in multiple types. These substances do not prove that there is a tumor: we also find them in other diseases and even in healthy people. So the result alone does not say everything. Tumor markers can help us make a diagnosis, but only in combination with other research.
Above all, they tell a hospital a lot about the course of your disease.
This site tells you which tumor markers can be determined for different types of cancers.
You agree to send the results to Blood Value Test and accept the possibility that mentally incriminating results may be found.
We can only perform the tests and provide you with the measured values, for further interpretation of these tests you should refer to a medical specialist.